Mucin4 (MUC4) Antibody Labeled with an NIR Dye Brightly Targets Pancreatic Cancer Liver Metastases and Peritoneal Carcinomatosis
Anti-MUC4-IR800 was able to successfully target and brightly label metastatic pancreatic cancer as small as 1 mm. Future clinical applications of the results of the present study are discussed.
Authors
- Kavita Mallya (ORCID: https://orcid.org/0000-0001-6562-5827)
- Sunidhi Jaiswal
- Sumbal Talib (ORCID: https://orcid.org/0000-0001-7141-740X)
- Michael Bouvet (ORCID: https://orcid.org/0000-0002-0086-2159)
- Robert M. Hoffman (ORCID: https://orcid.org/0000-0002-0049-0041)
- Aaron M. Mohs (ORCID: https://orcid.org/0000-0002-9353-5404)
- Siamak Amirfakhri
- Surinder K. Batra (ORCID: https://orcid.org/0000-0001-9470-9317)
- Javier Bravo (ORCID: https://orcid.org/0000-0001-9636-6717)
- Maneesh Jain
- Abhijit Aithal
- Keita Kobayashi
Institutions
- University of California San Diego (US)
- VA San Diego Healthcare System (US)
- AntiCancer (United States) (US)
- University of Nebraska Medical Center (US)
Publication Details
- Journal
- Cancers
- Published
- 2025-06-18
- DOI
- https://doi.org/10.3390/cancers17122031
- Citations
- 1
- Primary Topic
- Cancer Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.23